Global Hyperimmune Globulins Market Insights and Forecast to 2028

Report ID: 1123077 | Published Date: Jan 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Hyperimmune Globulins Product Introduction
    1.2 Market by Type
        1.2.1 Global Hyperimmune Globulins Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Hepatitis B Immunoglobulins
        1.2.3 Rabies Immunoglobulins
        1.2.4 Tetanus Immunoglobulins
        1.2.5 Rho(D) Immunoglobulins
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Hyperimmune Globulins Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Government Institutions
        1.3.3 Private Sector
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Hyperimmune Globulins Sales Estimates and Forecasts 2017-2028
    2.2 Global Hyperimmune Globulins Revenue Estimates and Forecasts 2017-2028
    2.3 Global Hyperimmune Globulins Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Hyperimmune Globulins Sales by Region
        2.4.1 Global Hyperimmune Globulins Sales by Region (2017-2022)
        2.4.2 Global Sales Hyperimmune Globulins by Region (2023-2028)
    2.5 Global Hyperimmune Globulins Revenue by Region
        2.5.1 Global Hyperimmune Globulins Revenue by Region (2017-2022)
        2.5.2 Global Hyperimmune Globulins Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Hyperimmune Globulins Sales by Manufacturers
        3.1.1 Global Top Hyperimmune Globulins Manufacturers by Sales (2017-2022)
        3.1.2 Global Hyperimmune Globulins Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hyperimmune Globulins in 2021
    3.2 Global Hyperimmune Globulins Revenue by Manufacturers
        3.2.1 Global Hyperimmune Globulins Revenue by Manufacturers (2017-2022)
        3.2.2 Global Hyperimmune Globulins Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Hyperimmune Globulins Revenue in 2021
    3.3 Global Hyperimmune Globulins Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Hyperimmune Globulins Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Hyperimmune Globulins Sales by Type
        4.1.1 Global Hyperimmune Globulins Historical Sales by Type (2017-2022)
        4.1.2 Global Hyperimmune Globulins Forecasted Sales by Type (2023-2028)
        4.1.3 Global Hyperimmune Globulins Sales Market Share by Type (2017-2028)
    4.2 Global Hyperimmune Globulins Revenue by Type
        4.2.1 Global Hyperimmune Globulins Historical Revenue by Type (2017-2022)
        4.2.2 Global Hyperimmune Globulins Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Hyperimmune Globulins Revenue Market Share by Type (2017-2028)
    4.3 Global Hyperimmune Globulins Price by Type
        4.3.1 Global Hyperimmune Globulins Price by Type (2017-2022)
        4.3.2 Global Hyperimmune Globulins Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Hyperimmune Globulins Sales by Application
        5.1.1 Global Hyperimmune Globulins Historical Sales by Application (2017-2022)
        5.1.2 Global Hyperimmune Globulins Forecasted Sales by Application (2023-2028)
        5.1.3 Global Hyperimmune Globulins Sales Market Share by Application (2017-2028)
    5.2 Global Hyperimmune Globulins Revenue by Application
        5.2.1 Global Hyperimmune Globulins Historical Revenue by Application (2017-2022)
        5.2.2 Global Hyperimmune Globulins Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Hyperimmune Globulins Revenue Market Share by Application (2017-2028)
    5.3 Global Hyperimmune Globulins Price by Application
        5.3.1 Global Hyperimmune Globulins Price by Application (2017-2022)
        5.3.2 Global Hyperimmune Globulins Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Hyperimmune Globulins Market Size by Type
        6.1.1 North America Hyperimmune Globulins Sales by Type (2017-2028)
        6.1.2 North America Hyperimmune Globulins Revenue by Type (2017-2028)
    6.2 North America Hyperimmune Globulins Market Size by Application
        6.2.1 North America Hyperimmune Globulins Sales by Application (2017-2028)
        6.2.2 North America Hyperimmune Globulins Revenue by Application (2017-2028)
    6.3 North America Hyperimmune Globulins Market Size by Country
        6.3.1 North America Hyperimmune Globulins Sales by Country (2017-2028)
        6.3.2 North America Hyperimmune Globulins Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Hyperimmune Globulins Market Size by Type
        7.1.1 Europe Hyperimmune Globulins Sales by Type (2017-2028)
        7.1.2 Europe Hyperimmune Globulins Revenue by Type (2017-2028)
    7.2 Europe Hyperimmune Globulins Market Size by Application
        7.2.1 Europe Hyperimmune Globulins Sales by Application (2017-2028)
        7.2.2 Europe Hyperimmune Globulins Revenue by Application (2017-2028)
    7.3 Europe Hyperimmune Globulins Market Size by Country
        7.3.1 Europe Hyperimmune Globulins Sales by Country (2017-2028)
        7.3.2 Europe Hyperimmune Globulins Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Hyperimmune Globulins Market Size by Type
        8.1.1 Asia Pacific Hyperimmune Globulins Sales by Type (2017-2028)
        8.1.2 Asia Pacific Hyperimmune Globulins Revenue by Type (2017-2028)
    8.2 Asia Pacific Hyperimmune Globulins Market Size by Application
        8.2.1 Asia Pacific Hyperimmune Globulins Sales by Application (2017-2028)
        8.2.2 Asia Pacific Hyperimmune Globulins Revenue by Application (2017-2028)
    8.3 Asia Pacific Hyperimmune Globulins Market Size by Region
        8.3.1 Asia Pacific Hyperimmune Globulins Sales by Region (2017-2028)
        8.3.2 Asia Pacific Hyperimmune Globulins Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Hyperimmune Globulins Market Size by Type
        9.1.1 Latin America Hyperimmune Globulins Sales by Type (2017-2028)
        9.1.2 Latin America Hyperimmune Globulins Revenue by Type (2017-2028)
    9.2 Latin America Hyperimmune Globulins Market Size by Application
        9.2.1 Latin America Hyperimmune Globulins Sales by Application (2017-2028)
        9.2.2 Latin America Hyperimmune Globulins Revenue by Application (2017-2028)
    9.3 Latin America Hyperimmune Globulins Market Size by Country
        9.3.1 Latin America Hyperimmune Globulins Sales by Country (2017-2028)
        9.3.2 Latin America Hyperimmune Globulins Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Hyperimmune Globulins Market Size by Type
        10.1.1 Middle East and Africa Hyperimmune Globulins Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Hyperimmune Globulins Revenue by Type (2017-2028)
    10.2 Middle East and Africa Hyperimmune Globulins Market Size by Application
        10.2.1 Middle East and Africa Hyperimmune Globulins Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Hyperimmune Globulins Revenue by Application (2017-2028)
    10.3 Middle East and Africa Hyperimmune Globulins Market Size by Country
        10.3.1 Middle East and Africa Hyperimmune Globulins Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Hyperimmune Globulins Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 CSL Behring
        11.1.1 CSL Behring Corporation Information
        11.1.2 CSL Behring Overview
        11.1.3 CSL Behring Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 CSL Behring Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 CSL Behring Recent Developments
    11.2 Grifols
        11.2.1 Grifols Corporation Information
        11.2.2 Grifols Overview
        11.2.3 Grifols Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Grifols Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Grifols Recent Developments
    11.3 Biotest
        11.3.1 Biotest Corporation Information
        11.3.2 Biotest Overview
        11.3.3 Biotest Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Biotest Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Biotest Recent Developments
    11.4 Kedrion
        11.4.1 Kedrion Corporation Information
        11.4.2 Kedrion Overview
        11.4.3 Kedrion Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Kedrion Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Kedrion Recent Developments
    11.5 CBPO
        11.5.1 CBPO Corporation Information
        11.5.2 CBPO Overview
        11.5.3 CBPO Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 CBPO Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 CBPO Recent Developments
    11.6 Emergent (Cangene)
        11.6.1 Emergent (Cangene) Corporation Information
        11.6.2 Emergent (Cangene) Overview
        11.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Emergent (Cangene) Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Emergent (Cangene) Recent Developments
    11.7 Kamada
        11.7.1 Kamada Corporation Information
        11.7.2 Kamada Overview
        11.7.3 Kamada Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Kamada Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Kamada Recent Developments
    11.8 CNBG
        11.8.1 CNBG Corporation Information
        11.8.2 CNBG Overview
        11.8.3 CNBG Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 CNBG Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 CNBG Recent Developments
    11.9 Hualan Bio
        11.9.1 Hualan Bio Corporation Information
        11.9.2 Hualan Bio Overview
        11.9.3 Hualan Bio Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Hualan Bio Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Hualan Bio Recent Developments
    11.10 Shanghai RAAS
        11.10.1 Shanghai RAAS Corporation Information
        11.10.2 Shanghai RAAS Overview
        11.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Shanghai RAAS Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Shanghai RAAS Recent Developments
    11.11 Sichuan Yuanda Shuyang
        11.11.1 Sichuan Yuanda Shuyang Corporation Information
        11.11.2 Sichuan Yuanda Shuyang Overview
        11.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Sichuan Yuanda Shuyang Recent Developments
    11.12 ADMA Biologics
        11.12.1 ADMA Biologics Corporation Information
        11.12.2 ADMA Biologics Overview
        11.12.3 ADMA Biologics Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 ADMA Biologics Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 ADMA Biologics Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Hyperimmune Globulins Industry Chain Analysis
    12.2 Hyperimmune Globulins Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Hyperimmune Globulins Production Mode & Process
    12.4 Hyperimmune Globulins Sales and Marketing
        12.4.1 Hyperimmune Globulins Sales Channels
        12.4.2 Hyperimmune Globulins Distributors
    12.5 Hyperimmune Globulins Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Hyperimmune Globulins Industry Trends
    13.2 Hyperimmune Globulins Market Drivers
    13.3 Hyperimmune Globulins Market Challenges
    13.4 Hyperimmune Globulins Market Restraints
14 Key Findings in The Global Hyperimmune Globulins Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Hyperimmune Globulins Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Hepatitis B Immunoglobulins
    Table 3. Major Manufacturers of Rabies Immunoglobulins
    Table 4. Major Manufacturers of Tetanus Immunoglobulins
    Table 5. Major Manufacturers of Rho(D) Immunoglobulins
    Table 6. Major Manufacturers of Other
    Table 7. Global Hyperimmune Globulins Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Hyperimmune Globulins Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Hyperimmune Globulins Sales by Region (2017-2022) & (K Units)
    Table 10. Global Hyperimmune Globulins Sales Market Share by Region (2017-2022)
    Table 11. Global Hyperimmune Globulins Sales by Region (2023-2028) & (K Units)
    Table 12. Global Hyperimmune Globulins Sales Market Share by Region (2023-2028)
    Table 13. Global Hyperimmune Globulins Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Hyperimmune Globulins Revenue Market Share by Region (2017-2022)
    Table 15. Global Hyperimmune Globulins Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Hyperimmune Globulins Revenue Market Share by Region (2023-2028)
    Table 17. Global Hyperimmune Globulins Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Hyperimmune Globulins Sales Share by Manufacturers (2017-2022)
    Table 19. Global Hyperimmune Globulins Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Hyperimmune Globulins Revenue Share by Manufacturers (2017-2022)
    Table 21. Hyperimmune Globulins Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Hyperimmune Globulins Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Hyperimmune Globulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperimmune Globulins as of 2021)
    Table 24. Hyperimmune Globulins Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Hyperimmune Globulins Product Offered
    Table 26. Date of Manufacturers Enter into Hyperimmune Globulins Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Hyperimmune Globulins Sales by Type (2017-2022) & (K Units)
    Table 29. Global Hyperimmune Globulins Sales by Type (2023-2028) & (K Units)
    Table 30. Global Hyperimmune Globulins Sales Share by Type (2017-2022)
    Table 31. Global Hyperimmune Globulins Sales Share by Type (2023-2028)
    Table 32. Global Hyperimmune Globulins Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Hyperimmune Globulins Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Hyperimmune Globulins Revenue Share by Type (2017-2022)
    Table 35. Global Hyperimmune Globulins Revenue Share by Type (2023-2028)
    Table 36. Hyperimmune Globulins Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Hyperimmune Globulins Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Hyperimmune Globulins Sales by Application (2017-2022) & (K Units)
    Table 39. Global Hyperimmune Globulins Sales by Application (2023-2028) & (K Units)
    Table 40. Global Hyperimmune Globulins Sales Share by Application (2017-2022)
    Table 41. Global Hyperimmune Globulins Sales Share by Application (2023-2028)
    Table 42. Global Hyperimmune Globulins Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Hyperimmune Globulins Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Hyperimmune Globulins Revenue Share by Application (2017-2022)
    Table 45. Global Hyperimmune Globulins Revenue Share by Application (2023-2028)
    Table 46. Hyperimmune Globulins Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Hyperimmune Globulins Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Hyperimmune Globulins Sales by Type (2017-2022) & (K Units)
    Table 49. North America Hyperimmune Globulins Sales by Type (2023-2028) & (K Units)
    Table 50. North America Hyperimmune Globulins Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Hyperimmune Globulins Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Hyperimmune Globulins Sales by Application (2017-2022) & (K Units)
    Table 53. North America Hyperimmune Globulins Sales by Application (2023-2028) & (K Units)
    Table 54. North America Hyperimmune Globulins Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Hyperimmune Globulins Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Hyperimmune Globulins Sales by Country (2017-2022) & (K Units)
    Table 57. North America Hyperimmune Globulins Sales by Country (2023-2028) & (K Units)
    Table 58. North America Hyperimmune Globulins Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Hyperimmune Globulins Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Hyperimmune Globulins Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Hyperimmune Globulins Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Hyperimmune Globulins Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Hyperimmune Globulins Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Hyperimmune Globulins Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Hyperimmune Globulins Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Hyperimmune Globulins Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Hyperimmune Globulins Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Hyperimmune Globulins Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Hyperimmune Globulins Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Hyperimmune Globulins Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Hyperimmune Globulins Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Hyperimmune Globulins Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Hyperimmune Globulins Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Hyperimmune Globulins Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Hyperimmune Globulins Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Hyperimmune Globulins Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Hyperimmune Globulins Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Hyperimmune Globulins Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Hyperimmune Globulins Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Hyperimmune Globulins Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Hyperimmune Globulins Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Hyperimmune Globulins Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Hyperimmune Globulins Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Hyperimmune Globulins Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Hyperimmune Globulins Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Hyperimmune Globulins Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Hyperimmune Globulins Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Hyperimmune Globulins Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Hyperimmune Globulins Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Hyperimmune Globulins Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Hyperimmune Globulins Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Hyperimmune Globulins Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Hyperimmune Globulins Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Hyperimmune Globulins Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Hyperimmune Globulins Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Hyperimmune Globulins Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Hyperimmune Globulins Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Hyperimmune Globulins Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Hyperimmune Globulins Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Hyperimmune Globulins Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Hyperimmune Globulins Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Hyperimmune Globulins Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Hyperimmune Globulins Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Hyperimmune Globulins Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Hyperimmune Globulins Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Hyperimmune Globulins Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Hyperimmune Globulins Revenue by Country (2023-2028) & (US$ Million)
    Table 108. CSL Behring Corporation Information
    Table 109. CSL Behring Description and Major Businesses
    Table 110. CSL Behring Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. CSL Behring Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. CSL Behring Recent Developments
    Table 113. Grifols Corporation Information
    Table 114. Grifols Description and Major Businesses
    Table 115. Grifols Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Grifols Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Grifols Recent Developments
    Table 118. Biotest Corporation Information
    Table 119. Biotest Description and Major Businesses
    Table 120. Biotest Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Biotest Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Biotest Recent Developments
    Table 123. Kedrion Corporation Information
    Table 124. Kedrion Description and Major Businesses
    Table 125. Kedrion Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. Kedrion Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Kedrion Recent Developments
    Table 128. CBPO Corporation Information
    Table 129. CBPO Description and Major Businesses
    Table 130. CBPO Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. CBPO Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. CBPO Recent Developments
    Table 133. Emergent (Cangene) Corporation Information
    Table 134. Emergent (Cangene) Description and Major Businesses
    Table 135. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Emergent (Cangene) Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Emergent (Cangene) Recent Developments
    Table 138. Kamada Corporation Information
    Table 139. Kamada Description and Major Businesses
    Table 140. Kamada Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Kamada Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Kamada Recent Developments
    Table 143. CNBG Corporation Information
    Table 144. CNBG Description and Major Businesses
    Table 145. CNBG Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. CNBG Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. CNBG Recent Developments
    Table 148. Hualan Bio Corporation Information
    Table 149. Hualan Bio Description and Major Businesses
    Table 150. Hualan Bio Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. Hualan Bio Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Hualan Bio Recent Developments
    Table 153. Shanghai RAAS Corporation Information
    Table 154. Shanghai RAAS Description and Major Businesses
    Table 155. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 156. Shanghai RAAS Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Shanghai RAAS Recent Developments
    Table 158. Sichuan Yuanda Shuyang Corporation Information
    Table 159. Sichuan Yuanda Shuyang Description and Major Businesses
    Table 160. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 161. Sichuan Yuanda Shuyang Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Sichuan Yuanda Shuyang Recent Developments
    Table 163. ADMA Biologics Corporation Information
    Table 164. ADMA Biologics Description and Major Businesses
    Table 165. ADMA Biologics Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 166. ADMA Biologics Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. ADMA Biologics Recent Developments
    Table 168. Key Raw Materials Lists
    Table 169. Raw Materials Key Suppliers Lists
    Table 170. Hyperimmune Globulins Distributors List
    Table 171. Hyperimmune Globulins Customers List
    Table 172. Hyperimmune Globulins Market Trends
    Table 173. Hyperimmune Globulins Market Drivers
    Table 174. Hyperimmune Globulins Market Challenges
    Table 175. Hyperimmune Globulins Market Restraints
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hyperimmune Globulins Product Picture
    Figure 3. Global Hyperimmune Globulins Market Share by Type in 2021 & 2028
    Figure 3. Hepatitis B Immunoglobulins Product Picture
    Figure 4. Rabies Immunoglobulins Product Picture
    Figure 5. Tetanus Immunoglobulins Product Picture
    Figure 6. Rho(D) Immunoglobulins Product Picture
    Figure 7. Other Product Picture
    Figure 8. Global Hyperimmune Globulins Market Share by Application in 2021 & 2028
    Figure 9. Government Institutions
    Figure 10. Private Sector
    Figure 11. Other
    Figure 12. Hyperimmune Globulins Report Years Considered
    Figure 13. Global Hyperimmune Globulins Sales 2017-2028 (K Units)
    Figure 14. Global Hyperimmune Globulins Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Hyperimmune Globulins Revenue 2017-2028 (US$ Million)
    Figure 16. Global Hyperimmune Globulins Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Hyperimmune Globulins Sales Market Share by Region (2017-2022)
    Figure 18. Global Hyperimmune Globulins Sales Market Share by Region (2023-2028)
    Figure 19. North America Hyperimmune Globulins Sales YoY (2017-2028) & (K Units)
    Figure 20. North America Hyperimmune Globulins Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Hyperimmune Globulins Sales YoY (2017-2028) & (K Units)
    Figure 22. Europe Hyperimmune Globulins Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Hyperimmune Globulins Sales YoY (2017-2028) & (K Units)
    Figure 24. Asia-Pacific Hyperimmune Globulins Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Hyperimmune Globulins Sales YoY (2017-2028) & (K Units)
    Figure 26. Latin America Hyperimmune Globulins Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Hyperimmune Globulins Sales YoY (2017-2028) & (K Units)
    Figure 28. Middle East & Africa Hyperimmune Globulins Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Hyperimmune Globulins Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Hyperimmune Globulins in the World: Market Share by Hyperimmune Globulins Revenue in 2021
    Figure 31. Global Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Hyperimmune Globulins Sales Market Share by Type (2017-2028)
    Figure 33. Global Hyperimmune Globulins Revenue Market Share by Type (2017-2028)
    Figure 34. Global Hyperimmune Globulins Sales Market Share by Application (2017-2028)
    Figure 35. Global Hyperimmune Globulins Revenue Market Share by Application (2017-2028)
    Figure 36. North America Hyperimmune Globulins Sales Market Share by Type (2017-2028)
    Figure 37. North America Hyperimmune Globulins Revenue Market Share by Type (2017-2028)
    Figure 38. North America Hyperimmune Globulins Sales Market Share by Application (2017-2028)
    Figure 39. North America Hyperimmune Globulins Revenue Market Share by Application (2017-2028)
    Figure 40. North America Hyperimmune Globulins Sales Share by Country (2017-2028)
    Figure 41. North America Hyperimmune Globulins Revenue Share by Country (2017-2028)
    Figure 42. U.S. Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Hyperimmune Globulins Sales Market Share by Type (2017-2028)
    Figure 45. Europe Hyperimmune Globulins Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Hyperimmune Globulins Sales Market Share by Application (2017-2028)
    Figure 47. Europe Hyperimmune Globulins Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Hyperimmune Globulins Sales Share by Country (2017-2028)
    Figure 49. Europe Hyperimmune Globulins Revenue Share by Country (2017-2028)
    Figure 50. Germany Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 51. France Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Hyperimmune Globulins Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Hyperimmune Globulins Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Hyperimmune Globulins Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Hyperimmune Globulins Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Hyperimmune Globulins Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Hyperimmune Globulins Revenue Share by Region (2017-2028)
    Figure 61. China Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 64. India Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Hyperimmune Globulins Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Hyperimmune Globulins Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Hyperimmune Globulins Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Hyperimmune Globulins Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Hyperimmune Globulins Sales Share by Country (2017-2028)
    Figure 76. Latin America Hyperimmune Globulins Revenue Share by Country (2017-2028)
    Figure 77. Mexico Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Hyperimmune Globulins Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Hyperimmune Globulins Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Hyperimmune Globulins Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Hyperimmune Globulins Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Hyperimmune Globulins Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Hyperimmune Globulins Revenue Share by Country (2017-2028)
    Figure 86. Turkey Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Hyperimmune Globulins Revenue (2017-2028) & (US$ Million)
    Figure 89. Hyperimmune Globulins Value Chain
    Figure 90. Hyperimmune Globulins Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Frequently Asked Questions
Hyperimmune Globulins report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hyperimmune Globulins report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hyperimmune Globulins report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hydrocyclone

Hydrocyclone market is segmented by Type and by Application. Players, stakeholders, and other par ... Read More